Interventional technology firm Medtronic has introduced its Talent abdominal stent graft in the U.S.
The combination of Talent and Medtronic's Xcelerant hydro delivery system is designed to aid endovascular aortic repair (EVAR) treatments, according to the Minneapolis-based firm.
Related Reading
Medtronic gets CE Mark for MRI pacemaker, November 17, 2008
Medtronic completes CryoCath buyout, November 13, 2008
Road to RSNA, MRI, Medtronic, October 31, 2008
BrainLab wins settlement from Medtronic, October 3, 2008
Medtronic to acquire CryoCath, September 25, 2008
Copyright © 2008 AuntMinnie.com